NCT05577819 - Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF | Biotech Hunter

Enrollment

515

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Transthyretin AmyloidosisHeart FailureHeart Failure, DiastolicAmyloidosis

Interventions

DIAGNOSTIC_TEST

99mTc-pyrophosphate Scintigraphy

Cardiac Imaging Technique used to diagnose Transthyretin Cardiac Amyloidosis by use of 15 mCi of 99mTC-Pyrophosphate tracer

Trial Locations (1)

RECRUITING

Massachusetts General Hospital, Boston